# Red Capital

> Red Capital is a VC fund backing Biopharma and Health Care. See 1 investments, check sizes, portfolio and contact details. Updated Sep 2026.

- Type: VC Fund
- Total investments: 1
- Last investment: Sep 2026
- Lead investor: 0%
- Last updated: Sep 2026
- Website: https://redcapital.vc

Red Capital is a healthcare-focused venture capital firm dedicated to advancing innovation across the life sciences ecosystem.

## Contacts

5 contacts available for Red Capital. Shizune tracks 1 team members at Red Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/red-capital-f1a7?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biopharma | 1 | 100% |
| Health Care | 1 | 100% |
| Biotechnology | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Tomoko Inoue | Managing Partner & Founder | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| SiccaNova Therapeutics | SiccaNova Therapeutics is a Japanese biopharmaceutical company dedicated to treating sicca (dryness) related medical conditions. The company’s lead drug candidate, XF8302, is a novel, small-molecule M3 muscarine receptor Positive Allosteric Modulator (M3 PAM). Developed initially for dry mouth in Sjögren’s syndrome patients, the drug enhancesnatural acetylcholine signaling to stimulate salivation without the systemic side effects common in traditional agonists. | $7.9M | Series A | Sep 03, 2026 | https://www.siccanova.com/ |

1 of 1 investments shown.

## Co-investors
- [77 Partners](https://shizune.co/investors/profile/77-partners) — VC Fund, 1 deal together
- [JIC Venture Growth Investments](https://shizune.co/investors/profile/jic-venture-growth-investments) — VC Fund, 1 deal together
- [Joyo Capital Partners](https://shizune.co/investors/profile/joyo-capital-partners) — VC Fund, 1 deal together
- [MPower Partners](https://shizune.co/investors/profile/mpower-partners) — VC Fund, 1 deal together
- [Tohoku University Venture Partners](https://shizune.co/investors/profile/tohoku-university-venture-partners) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Red Capital invest in?

Red Capital invests primarily in Biopharma, Health Care and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Red Capital?

Public channels for Red Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Red Capital?

The team at Red Capital includes Tomoko Inoue (Managing Partner & Founder). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co